thomps1523
Established Member
- Reaction score
- 298
I do think that a solution to the inductivity problem will be announced soon since scientists are really focusing on this issue now, they're trying new things, and they appear to be getting close to a solution.
But keep in mind that the Replicel study we talk about was publicized over 5 years ago. This means that treatment is well over 5 years old. It's probably at least 6 or 7 years old. And it's the same treatment they want to proceed with in clinical trials now. So if their present treatment works that would mean that they alone figured out a solution to the inductivity problem at least 6 or 7 years ago and for some reason they're keeping that fact a secret and not mentioning the technique in their patent.
I really don't think so.
Replicel is old. I think that Replicel is part of the old Intercytex and Aderans wave, from back before the scientific community decided they have to take the inductivity problem seriously. When Aderans and Intercytex failed (due to the inductivity problem) they didn't go down easy. They resisted going under. I think Replicel is doing the same thing.
I hope I'm wrong but I think I'm right.
Do you expect sheisido's results to answer this question?